Supernus pharmaceuticals, inc. (SUPN)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Revenues
Total revenues

402,257

392,755

408,243

409,099

403,942

408,897

381,398

358,800

335,091

302,238

276,176

252,588

228,385

215,003

196,317

178,869

162,921

147,465

135,013

118,338

112,335

92,678

71,777

50,347

20,953

12,019

1,776

610

0

-

0

0

-

-

-

-

-

Costs and expenses
Cost of goods sold

17,128

16,660

16,735

16,123

15,762

15,356

15,322

15,366

15,544

15,215

14,833

14,010

12,900

11,986

11,009

9,829

8,840

8,423

7,910

6,983

6,882

5,758

3,509

2,192

0

-

0

0

-

-

-

-

-

-

-

-

-

Research and development

72,642

69,099

79,148

82,627

85,695

89,209

75,541

68,099

58,884

49,577

46,656

41,544

41,830

42,791

38,984

40,245

36,014

29,135

25,460

20,988

18,787

19,586

19,218

18,340

17,205

17,245

16,993

21,520

22,681

23,517

25,867

25,986

28,534

30,627

0

0

0

Selling, general and administrative

160,332

158,425

164,750

164,993

164,007

159,888

151,602

151,535

146,516

137,905

133,195

118,045

109,088

106,010

100,522

97,747

94,820

89,063

83,556

78,101

74,488

72,612

69,776

66,951

59,584

55,590

49,051

38,506

30,937

20,132

14,233

11,659

8,909

7,928

0

0

0

Total costs and expenses

250,102

244,184

260,633

263,743

265,464

264,453

242,465

235,000

220,944

202,697

194,684

173,599

163,818

160,787

150,515

147,821

139,674

126,621

116,926

106,072

100,157

97,956

93,537

88,546

78,387

73,939

66,081

60,030

53,618

43,649

40,100

37,645

37,443

38,555

0

0

0

Operating earnings

152,155

148,571

147,610

145,356

138,478

144,444

138,933

123,800

114,147

99,541

81,492

78,989

64,567

54,216

45,802

31,048

23,247

20,844

18,087

12,266

12,178

-5,278

-21,760

-38,199

-57,434

-61,920

-63,306

-58,421

-52,199

-42,169

-39,668

-37,293

-36,432

-37,752

0

0

0

Other income (expense)
Interest expense

0

-

-

-

0

-

-

-

-

1,568

114

316

454

543

802

892

1,027

1,229

2,193

3,190

4,137

4,963

5,882

7,463

8,329

7,849

6,545

4,555

3,340

3,575

3,279

2,898

2,468

1,866

0

0

0

Interest income, net

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

2,398

1,962

1,671

1,467

1,332

1,123

895

681

502

411

359

348

361

379

349

299

233

176

153

120

91

55

35

31

0

0

0

Interest expense on non-recourse liability related to sale of future royalties

-

-

-

-

-

-

-

-

-

-

2,258

3,107

4,228

4,548

4,575

4,569

4,061

3,541

2,856

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in fair value of derivative liabilities

-

-

-

-

-

-

-

-

-

-

175

301

401

448

476

465

343

193

760

1,406

2,083

2,809

1,453

-3,460

-12,757

-13,354

-12,986

-8,977

0

-

0

0

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-584

-493

-390

-671

-320

-345

-586

-2,338

-2,400

-3,235

-3,033

-2,592

-3,754

0

0

-

-

0

-

-

-

-

-

-

-

-

-

Total other income (expense)

127

-1,084

-2,268

-3,233

-5,245

-4,268

0

0

0

-

-

-

-

-

-

-

-

-

0

0

-

-

0

-

-

101

365

302

595

50

-57

260

-82

202

0

0

0

Total other income (expense)

-

-

-

-

-

-

-

-

-

-

-382

-1,653

-3,000

-3,847

-3,919

-4,243

-4,436

-6,234

-6,126

-6,734

-6,106

-5,017

-15,358

-20,644

-31,968

-30,353

-20,073

-14,344

-3,222

-4,115

-3,768

-2,812

-2,600

-1,718

0

0

0

Earnings before income taxes

152,282

147,487

145,342

142,123

133,233

140,176

136,469

123,008

115,577

100,618

81,110

77,336

61,567

50,369

41,883

26,805

18,811

14,610

11,961

5,532

6,072

-10,295

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Income tax expense

36,048

34,431

39,522

37,152

30,252

29,183

37,711

36,300

42,238

43,334

23,165

-26,474

-35,126

-40,852

-41,872

960

780

666

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-23,225

0

0

0

Income from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

77,040

0

0

0

Net earnings

116,234

113,056

105,820

104,971

102,981

110,993

98,758

86,708

73,339

57,284

57,945

103,810

96,693

91,221

83,755

25,845

18,031

13,944

10,878

4,591

5,356

-10,925

-37,118

-58,843

-89,402

-92,273

-83,379

-72,765

-55,421

-46,284

49,203

52,951

55,587

53,815

0

0

0

Cumulative dividends on Series A convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,143

1,999

2,858

3,430

3,430

0

0

0

Net income (loss) attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-47,427

47,203

50,093

52,157

50,385

0

0

0

Basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30,875

-

24,464

16,817

1,676

-

1,595

-

-

Earnings per share
Basic (in dollars per share)

0.41

0.64

0.55

0.62

0.35

0.49

0.54

0.59

0.51

0.27

0.31

0.34

0.21

0.28

1.25

0.21

0.10

0.14

0.08

0.05

0.02

0.10

-0.06

0.08

-0.38

-

-0.78

-0.89

-

-

-

-

-

-

-

-

-

Diluted (in dollars per share)

0.40

0.61

0.54

0.61

0.34

0.47

0.52

0.57

0.49

0.28

0.29

0.32

0.19

0.32

1.18

0.18

0.08

0.14

0.08

0.04

0.02

0.10

-0.06

0.08

-0.38

-

-0.78

-0.89

-

-

-

-

-

-

-

-

-

Net (loss) income per common share:
Continuing operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3.09

-6.90

-6.15

-6.64

Discontinued operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

47.59

0.26

0.98

-0.84

Basic and diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.60

-

-0.55

-0.61

-6.05

50.68

-6.64

-5.17

-7.48

Weighted-average shares outstanding
Basic (in shares)

52,534

52,473

52,453

52,385

52,336

52,275

52,227

51,919

51,536

51,290

51,046

50,530

50,158

49,705

49,516

49,427

49,240

48,950

48,515

47,911

44,563

42,957

42,900

42,056

41,129

-

30,941

30,897

-

-

-

-

-

-

-

1,594

1,592

Diluted (in shares)

53,581

53,562

53,805

53,912

53,985

54,163

54,239

54,203

53,788

53,588

53,628

53,223

52,764

51,964

51,974

51,745

51,152

55,875

51,590

52,273

44,901

42,642

42,900

42,372

41,129

-

30,941

30,897

-

-

-

-

-

-

-

1,594

1,592

Net product sales
Total revenues

392,791

383,400

398,985

399,178

393,850

399,871

372,711

350,550

326,848

294,097

268,863

246,415

223,422

210,078

191,590

174,523

158,454

143,526

131,429

115,330

108,673

89,571

60,186

37,888

0

-

0

0

-

-

-

-

0

-

0

0

-

Royalty revenues
Total revenues

9,466

9,355

9,258

9,921

9,342

8,276

7,865

7,106

6,527

6,367

5,560

4,690

4,716

4,686

4,495

4,131

3,552

3,038

2,206

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Licensing revenue
Total revenues

-

-

0

0

-

-

0

0

-

1,774

1,753

1,483

247

239

232

215

915

901

1,143

1,144

2,424

2,474

2,254

2,345

406

467

492

456

0

-

0

0

-

-

-

0

-